This inventor holds 1 USPTO granted patent. Top assignee: Schwarz Pharma Ag. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Adam Julian De Belder: Innovator in Transdermal Drug Delivery
Introduction
Adam Julian De Belder is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. His innovative approach has the potential to improve patient outcomes in various medical scenarios.
Latest Patents
Adam Julian De Belder holds a patent for the "Transdermal presentation of nitroglycerin for preventing undesired labor." This invention addresses a critical need in obstetrics by providing a non-invasive method to administer medication effectively.
Career Highlights
De Belder is associated with Schwarz Pharma AG, a company known for its focus on innovative pharmaceutical solutions. His work at the company has allowed him to contribute to advancements in drug delivery technologies.
Collaborations
Throughout his career, Adam has collaborated with esteemed colleagues such as Hans-Michael Wolff and Dietrich Wilhelm Schacht. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Adam Julian De Belder's contributions to transdermal drug delivery exemplify the impact of innovative thinking in the pharmaceutical industry. His work continues to pave the way for advancements that can enhance patient care and treatment efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile